Half of people arrested in London may have undiagnosed ADHD, according to a major new study that is calling for routine ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, ...

Adults with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) often lose access to specialized ...

LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.

Trauma can look like ADHD, but symptoms often derive from a child’s survival system, not a condition. Safety, regulation, and ...

Half of prisoners in London are believed to have undiagnosed attention deficit hyperactivity disorder ( ADHD ), according to ...

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and ...

Lumos Labs, announced today that the FDA has granted 510(k) clearance for LumosityRx, a prescription digital therapeutic for adults with ADHD.

Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the ...

Adults diagnosed with attention deficit hyperactivity disorder (ADHD) may have a shorter life expectancy than those without such a diagnosis, according to a new study that some experts have called ...

BETHESDA, Md., Dec. 10, 2025 /PRNewswire/ --HarmonEyes, the AI-driven eye-tracking software innovator, today announced the successful acquisition of iFocus Health, a clinically validated ADHD ...